GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » Insider Ownership

Acepodia (ROCO:6976) Insider Ownership : 0.00 % (As of Apr. 12, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Acepodia Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Acepodia's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Acepodia's Institutional Ownership is 0.04%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Acepodia's Float Percentage Of Total Shares Outstanding is 0.00%.


Acepodia Insider Ownership Historical Data

The historical data trend for Acepodia's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia Insider Ownership Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Insider Ownership
- - - - -

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Insider Ownership Get a 7-Day Free Trial - - - - -

Acepodia Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Acepodia Business Description

Traded in Other Exchanges
N/A
Address
17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia Headlines

No Headlines